Baughman, R. P., Judson, M., Culver, D., Birring, S., Parambil, J., Zeigler, J., & Lower, E. E. (2021). Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial. Sarcoidosis, Vasculitis and Diffuse Lung Disease, 38(3), e2021035. https://doi.org/10.36141/svdld.v38i3.11684